Find a TenderAwarded

Published 7 Sept 2021, 19:14 BST

Official UK procurement notice

Regulatory Work to Secure Licence Variation for anastrozole

Official notice

Authority: NHS England (Central government)

ServicesOpen procedure

Sectors: Medical Devices & Pharma (33)Health & Social Care (85) Delivery: UKYorkshire & Humber (UKE)

Budget not disclosed£1≈ £1 / year · 1 value update

Submissions closed 31 Jan 2022awarded 28 Apr 2022

Awarded to ACCORD-UK LTD

Contract term 1 yrends 31 Mar 2023 · starts 1 Apr 2022

What is being bought

Published requirement description

This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.

CPV: Pharmaceutical products · Pharmacy services

The lotProcurement structure

single lot · value published

Lot #1Awarded 1 yrPublished value£1

Contract period: 1 Apr 2022 – 31 Mar 2023 (1 yr)

Delivery: UK, Yorkshire & Humber · England

Variant bids: not allowed

33600000 Pharmaceutical products 85149000 Pharmacy services

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

How bids were scored

Price

Conditions of participation1

Suitability
Please see procurement documents

Procedure terms & legal framework

From the official record

Procedure method: Open procedure
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Services
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Competitive procedure
GPA / WTO covered: Yes (GPA)
Recurring procurement: No (one-off requirement)
First published: 7 Sept 2021, 19:14 BST
Last source update: 27 May 2022, 16:48 BST
Award evaluation window: 1 Feb 2022 – …
Authority reference: C52236
FTS notice number: 2022/S 000-014973
Classification (CPV): Pharmaceutical productsPharmacy services
Delivery area: UKYorkshire & Humber (UKE)
Official registry OCID: ocds-h6vhtk-02de26 Find a Tender

How it was run

Official notice

Run through: Atamis (Health Family) · Who buys & how to bid on Atamis

Supplier login requiredLanguage: EN

Access & registration note: Free · one account PER buying organisation portal · password resets come "from Salesforce.com" (check spam)

Tender documents are also served through a separate tool: http://health.atamis.co.uk ↗

Submission deadline: 31 Jan 2022, 13:00 GMT
Submission channel: {"electronicSubmission","written"}
Accepted languages: en
Bids opened: 1 Feb 2022, 09:00 GMT

Detailed submission instructions & authority contactsFrom official release

health.atamis.co.uk ↗

Timeline

1 Oct 2021 → 31 Mar 2023 · 6 dates

Next notice expected
1 Oct 2021, 00:00 BST
Submission deadline
31 Jan 2022, 13:00 GMT
Bids opened
1 Feb 2022, 09:00 GMT
Contract starts
1 Apr 2022, 00:00 BST
Notice published
27 May 2022, 16:48 BST
Bids must remain valid until
31 Mar 2023, 23:59 BST

Notice history

6 events · 4 releases on Find a Tender · since 19 Jan 2022

Published value published: £1
19 Jan 2022, 17:30 GMT
Status changed to active
19 Jan 2022, 17:30 GMT
Procurement method changed
19 Jan 2022, 17:30 GMT
Deadline moved to 31 Jan 2022, 13:00 GMT
19 Jan 2022, 17:30 GMT
-6 days · was 7 Feb 2022
Deadline published: 7 Feb 2022
19 Jan 2022, 17:30 GMT
Status changed to complete
27 May 2022, 16:48 BST

Published amendments (1 · 1 deadline change)

When	What	Before	After	Shift
—	TextShort description · II.1.4.1	—	This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. I…
—	DeadlineDeadline for EOI date · IV.2.2.1	31 Jan 2022	7 Feb 2022	+7 d
—	Bid openingTender opening date · IV.2.7.1	1 Feb 2022	8 Feb 2022	+7 d

1 amendment published without a description.

Routine re-releases (4)

2021-09: 1 release · 7 Sept 2021

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Bids received 3

Contracts signed 1latest 28 Apr 2022

Awarded to	Value	Date	Status
ACCORD-UK LTD	—	—	Awarded

Contracts

Contract 014973-2022-1 · ACCORD-UK LTD
Signed
28 Apr 2022
Value
—
Period
… – 31 Mar 2023
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
3bids · 3 electronic · 3 from abroad	—	—	£1 – £1

Contracting authority & participating public bodies

NHS England

Contracting authorityCentral GovernmentBody governed by public lawHealth Quarry House, Leeds, Yorkshire & Humber, LS2 7UEContact name, email Published organisation website ↗

Bidders & participating suppliers

1 commercial party on the notice

Accord-UK LtdAwarded supplier79585 Whiddon Valley, Barnstaple, Devon, EX32 8NS, Barnstaple, UK, EX32 8NS

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

Economic and financial selection criteriatenderEconomic and financial selection criteria
Technical selection criteriatenderTechnical selection criteria